View All Patents
EP2493466
NOVEL ANTITUMORAL USE OF CABAZITAXEL
Filed
Oct 27, 2010
Technology
Chemistry · Pharmaceuticals
UPC cases
26
EPO proceedings
2
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
Hover an owner to see their dates
- SANOFIsince Jan 10, 2025
- Sanofi Mature IPDec 6, 2019 – Jan 10, 2025
- Aventis Pharma S.A.Aug 3, 2012 – Dec 6, 2019
Abstract
The invention relates to a compound of Formula (I): which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
From the international application WO2011051894
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Feb 12, 2026 | UPC CoA 22/2026 | Court of Appeal | Appeal | Locked | Sanofi Mature IP +13 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in